The Preventative Benefits of Daily Aspirin Consumption
It has become the norm for people to use aspirin regularly as a means of lowering their risk of contracting ailments like heart attacks and strokes. However, these benefits have always been counterbalanced by the dangers daily aspirin consumption attracts, the most well-known of which is the fact that it can increase the risk of internal bleeding.
For this reason, doctors have always struggled with the question of either encouraging or discouraging regular aspirin use; that is until now. New studies have emerged in The Lancet, putting forward additional benefits of daily aspirin use that might make the risks it presents more than worth it.
According to Professor Peter Rothwell (Oxford University), middle-aged men and women who take aspirin on a daily basis can actually reduce their chances of developing all sorts of cancers. Along with preventing pre-existing and localized cancers from spreading to other parts of the body, Rothwell believes that the findings of his colleagues should change the direction of the aspirin debate.
It is difficult to compare the risk of internal bleeding posed by regular aspirin use to its ability to prevent cancer and reduce the risk of heart attacks and strokes. As far as some people are concerned, these new findings should compel even healthy individuals to consider the possibility of using aspirin on a daily basis if only to guarantee their health. It should be noted that Rothwell and his colleagues haven’t exactly come out to promote the daily use of aspirin.
However, it is clear that the question of aspirin usage should be revisited once more with the pros and cons carefully considered to determine whether the benefits of aspirin use are worth the risks.
At the present, most medical experts believe that a reduced dosage of aspirin can also decrease the risk of health complications like internal bleeding manifesting.
In a commentary on the subject that was also published in The Lancet, experts from the Brigham Women’s hospital and Harvard Medical School opposed the idea of actually recommending aspirin to prevent cancer, with some voices claiming that Rothwell’s trial simply wasn’t comprehensive enough to allow for the making of such drastic conclusions.
Even the harshest of opposing voices, though, agree that Rothwell’s work shows promise, and that additional research into this matter might be necessary to acquire more conclusive results about aspirin and its role as a preventative measure for cancer. For the moment, many physicians will continue to approach aspirin with some skepticism.